Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Glenmark Pharma gets USFDA nod for progesterone inserts; eyes $59 million market
Glenmark gets USFDA nod for 100 mg progesterone vaginal inserts, a generic to Endometrin, to be sold in US, targeting fertility care, Endometrin sales were $59.2 million dollars
Glenmark to directly commercialise Ryaltris in US, expanding innovative portfolio
Glenmark will directly commercialise RYALTRIS nasal spray in the US from April 1 2026 to strengthen its allergy portfolio, shares fell 1.7 percent to 2095.50 rupees
Raja Venkatraman, MarketSmith recommend five stocks for 20 March
On March 19, Nifty 50 and Sensex dropped over 3% due to HDFC Bank chairman's resignation and rising crude oil prices. Analysts recommend buying Ipca Laboratories, Great Eastern Shipping, Colgate Palmolive, Glenmark Pharmaceuticals, and Power Finance Corporation amid market volatility.
Glenmark Pharma launches Potassium Phosphates Injection in US market
The company said its Potassium Phosphates Injection is bioequivalent and therapeutically equivalent to the reference listed drug from Fresenius Kabi. Glenmark plans to begin distribution of the product in March 2026.
Glenmark Pharmaceuticals wins USFDA nod for fluticasone inhaler
Glenmark Pharmaceuticals has secured a significant approval from the US FDA for its inhaler fluticasone propionate. This marks a key step in strengthening the company's respiratory offerings in the US market. The product is set for distribution starting March. Glenmark's achievement includes a Competitive Generic Therapy designation, granting them 180 days of market exclusivity.
Glenmark wins US nod for Fluticasone inhaler, to get 180-day exclusivity
Glenmark Specialty SA has received US FDA approval for its Fluticasone Propionate inhalation aerosol, securing 180-day competitive generic therapy exclusivity in a market with annual sales of over $520 million.
Glenmark Pharma US arm to launch sodium phosphate injection, begin distribution in April
As per the IQVIA sales data for the 12 months ending December 2025, the sodium phosphate injection's single-dose vials market achieved annual sales of around $66.8 million.
Buy Glenmark Pharma; target of Rs 2610: Motilal Oswal
Motilal Oswal is bullish on Glenmark Pharma recommended buy rating on the stock with a target price of Rs 2610 in its research report dated June 01, 2026.
Stocks to Watch Today: InterGlobe Aviation, Concord Biotech, NMDC, Lumax Auto Tech, Olectra Greentech, Cyient. Lupin, PB Fintech in focus on 01 June
Stocks to Watch, 1 Jun: InterGlobe Aviation, Gujarat Gas, Concord Biotech, Indian Renewable Energy Development Agency, NMDC, Glenmark Pharma, Olectra Greentech, Lumax Auto Technologies, Inox Wind, PNC Infratech, and Cyient will be in focus on June 1.
Cipla, Sun Pharma, Dr Reddy's, Glenmark trade lower after Centre tightens cough syrup sales rules
The broader Nifty Pharma index also traded lower, falling 0.47% to 24,220.10.
Glenmark gets USFDA nod for generic Flovent with 180‑day CGT exclusivity
CGT designations are granted to medicines with limited generic competition, and first‑approved applicants are eligible for six months of exclusivity—an incentive aimed at encouraging development of hard‑to‑copy generics, particularly in categories like inhalation therapies where technical barriers are high.
Trade Spotlight: How should you trade Avenue Supermarts, Glenmark, Bharat Dynamics, Torrent Pharma, Cummins India, and others on March 10?
The market is expected to rebound after the severe correction, but the sustainability of the uptrend will be the key factor to watch. Below are some short-term trading ideas to consider.